Vol. 30.Issue. 1. January - February 2025 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

3.7

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

7.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.289

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

0.941

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 30. Issue 1. (In progress)

(January - February 2025)

This issue is in progress but contains articles that are final and fully citable.

Concise reviews

cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B

Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman

Full text access

Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy

Maria Stella Franzè, Paul Vigneron, Anna Sessa, Carlo Saitta, Julia Chalaye, Vania Tacher, Alain Luciani, Hélène Regnault, ... Giuliana Amaddeo

Full text access

Predictive role of microvesicles in cirrhotic patients: A promised land or a land of confusion? A narrative review

Andrea Boccatonda, Fabio Piscaglia

Full text access

A landscape of liver cirrhosis and transplantation in Mexico: Changing leading causes and transplant as response

Icela Palma-Lara, María Guadalupe Ortiz-López, José Bonilla-Delgado, Juanita Pérez-Escobar, Ricardo Godínez-Aguilar, Claudia Luévano-Contreras, Ana María Espinosa-García, Javier Pérez-Durán, ... Carmen Palacios-Reyes

Full text access

Original articles

Evaluation of four chatbots in autoimmune liver disease: A comparative analysis

Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, Roberto Rueda-Esteban, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bömmel, ... Andreas Teufel

Full text access

Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitis

Eleanor Belilos, Jessica Strzepka, Ethan Ritz, Nancy Reau, Costica Aloman

Full text access

Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value

Ying Zhang, Huaying Lai, Jing Chen, Ruimin Lai, Xiaoyu Lin, Shan Lin, Bingping Liu, Qiuxiang Lin, ... Qi Zheng

Full text access

The Toulouse algorithm identifies patients with increased risk of cardiac decompensation only in patients with TIPS for refractory ascites

Emma Vanderschueren, Youri Bekhuis, Jan Clerick, Jappe Decock, Philippe Meersseman, Alexander Wilmer, Eveline Claus, Lawrence Bonne, ... Wim Laleman

Full text access

Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease

Ashi Mittal, Nishu Choudhary, Sudrishti Chaudhary, Anupama Kumari, Archana Rastogi, Guresh Kumar, Jaswinder Singh Maras, Shiv K Sarin, Shvetank Sharma

Full text access

Gut-related molecules as potential biomarkers in patients with decompensated cirrhosis

Camila Marques de Alcântara Barreto, Eliane Almeida do Valle, Jessica Pronestino de Lima Moreira, Katia Farias e Silva, Siane Lopes Bittencourt Rosas, Patrícia Teixeira Santana, Ana Maria Pittella, Gustavo Pereira, ... Heitor Siffert Pereira de Souza

Full text access

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway

Ling Wang, Chuanzhong Huang, Wansong Lin, Zhifeng Zhou, Jieyu Li, Mingshui Chen, Lingyu Zhang, Yunbin Ye

Full text access

Soft drink consumption and increased risk of nonalcoholic fatty liver disease: Results from the health workers cohort study

Edgar Denova-Gutiérrez, Berenice Rivera-Paredez, Amado D. Quezada-Sánchez, Brianda I. Armenta-Guirado, Paloma Muñoz-Aguirre, Yvonne N. Flores, Rafael Velázquez-Cruz, Jorge Salmerón

Full text access

Knowledge about metabolic dysfunction-associated steatotic liver disease among the medical professionals from countries in the MENA region

Saleh A. Alqahtani, Yusuf Yilmaz, Mohamed El-Kassas, Khalid Alswat, Mohamed Mawardi, Faisal M. Sanai, Faisal Abaakhail, Saad Alghamdi, ... Global NASH Council

Full text access

Epidemiology and natural history of chronic Hepatitis B in the Canadian province of Alberta from 2012 to 2021: A population-based study

Golasa Samadi Kochaksaraei, Fengjuan Yang, Cynthia H. Seow, Herman W Barkema, Carla S Coffin, Abdel-Aziz Shaheen

Full text access

Efficacy of prophylactic antibiotics in the adjuvant treatment of alcohol-related liver disease (ALD): A systematic review and meta-analysisProphylactic antibiotics in ALD

Xiuyan Wang, Endian Zheng, Haoyue Sun, Beibei Xu, Liang Zheng, Yi Huang

Full text access

Letters to the editor

Development of a biodegradable prosthesis through tissue engineering: the lack of the physiological abstractions prevents bioengineering innovations

Ilya Klabukov, Anna Smirnova, Ekaterina Evstratova, Denis Baranovskii

Full text access

Development of a biodegradable prosthesis through tissue engineering, for the organ-replacement or substitution of the extrahepatic bile duct

Alan Isaac Valderrama-Treviño, Andrés E. Castell-Rodríguez, Rolando Hernández-Muñoz, Nadia A. Vázquez-Torres, Andrés Macari-Jorge, Baltazar Barrera-Mera, Alfredo Maciel-Cerda, Ricardo Vera-Graziano, Natalia Nuño-Lámbarri, Eduardo E. Montalvo-Javé

Full text access